Tonix Tweets ‘Tonix Pharmaceuticals CMO Dr. Gregory Sullivan will present results from the RELIEF study at this year’s @ACRheum Convergence 2021. This positive Phase 3 study investigated the use of TNX-102 SL for the management of #fibromyalgia.’

by | Nov 3, 2021 | Uncategorized | 0 comments

Meritas Media Team

Submit a Comment

Your email address will not be published. Required fields are marked *